Livongo IPO
Livongo was a digital health company that provided remote monitoring and personalized coaching for people with chronic conditions like diabetes and hypertension. The company used connected devices and data analytics to help patients manage their health while reducing healthcare costs. Livongo was acquired by Teladoc Health, creating significant value for investors in the rapidly growing digital health market.
What We Know
Livongo went public in July 2019 with an IPO that raised approximately $355 million, pricing at $28 per share. The stock performed well initially, reflecting strong investor interest in digital health solutions and the company's growth prospects in chronic care management. In October 2020, Livongo was acquired by Teladoc Health in an all-stock transaction valued at approximately $18.5 billion. The acquisition created a comprehensive virtual care platform combining Teladoc's telehealth services with Livongo's chronic care management capabilities. Livongo shareholders received Teladoc shares as part of the deal, which was completed in late 2020.
Frequently Asked Questions
Has Livongo had an IPO?
Yes, Livongo had an IPO in July 2019, but the company was subsequently acquired by Teladoc Health in October 2020. Livongo no longer exists as an independent public company.
When is the Livongo IPO date?
Livongo's IPO occurred in July 2019, but this is no longer relevant as the company was acquired. There will be no future Livongo IPO as it is now part of Teladoc Health.
How can I buy Livongo stock?
You cannot buy Livongo stock as the company was acquired by Teladoc Health in 2020. Former Livongo shareholders received Teladoc shares, which trade under the ticker TDOC.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts